Eric J. Friedman
CIK: 0001216280
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INTEGRATED BIOPHARMA INC
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jun 24, 2026INBP
INTEGRATED BIOPHARMA INC
Award(A)DirectStock Option (Right to Buy)
50K shares- - Jun 24, 2026INBP
INTEGRATED BIOPHARMA INC
Award(A)DirectStock Option (Right to Buy)
50K shares- - Jun 18, 2025INBP
INTEGRATED BIOPHARMA INC
Award(A)DirectStock Option (Right to Buy)
50K shares-
1-3 of 3 transactions
About Friedman Eric J
Friedman Eric J (SEC CIK 0001216280) files insider reports with the SEC as Director of INTEGRATED BIOPHARMA INC (INBP).
Signal8 holds 3 ownership filings by Friedman Eric J, all Form 4s, filed between Jun 20, 2025 and Jun 25, 2026. Those filings report 3 transactions, from Jun 18, 2025 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Friedman Eric J's filings is in HILLSIDE, NJ.
Recent filings by Friedman Eric J
Other insiders filing for INTEGRATED BIOPHARMA INC (INBP)
- DeSantis Damon, Director
- Canarick Robert, Director
- Milmoe William H., Director
- DESANTIS CARL, 10% Owner
- KAY CHRISTINA, Co-Chief Executive Officer
- RIVA SHEPPARD, Co-Chief Executive Officer